IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy

INTRODUCTION: IDegLira is a once-daily combination of insulin degludec (IDeg) and liraglutide. Trials directly comparing IDegLira with alternative strategies for intensifying basal insulin are ongoing. While awaiting results, this analysis compared indirectly how different strategies affected glycat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Ther
Glavni autori: Freemantle, Nick, Mamdani, Muhammad, Vilsbøll, Tina, Kongsø, Jens Harald, Kvist, Kajsa, Bain, Stephen C.
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2015
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674480/
https://ncbi.nlm.nih.gov/pubmed/26582052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-015-0142-y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items